Mineral Status in Pregnant Women
PREDISH
Evaluation of Mineral Status in Pregnant Women and Its Association With Fetal Development
1 other identifier
observational
550
1 country
1
Brief Summary
Ensuring an adequate supply of nutrients, which include trace elements, is particularly important in pregnancy. Both deficiency and excess of trace elements in the body can interfere with conception and maintaining a healthy pregnancy. The effects of malnutrition and shortages in fetal life may increase the risk of miscarriages, congenital malformations, premature births, intrauterine fetal growth restriction (IUGR) and more frequent perinatal mortality. Nutritional deficiencies during fetal development may also have long-term consequences for the child, such as disorders in his biological and psychomotor development. In women of procreative age, an adequate supply of minerals, especially iron, calcium, zinc, magnesium and copper, is very important. The results of clinical trials indicate an association of anemia in pregnant women with premature delivery and low birth weight of a newborn. Calcium deficiency leads to the development of hypertension in pregnancy (including preeclampsia) and increases the risk of premature birth. Deficiency of zinc and copper in the mother's body is associated with complications of pregnancy and childbirth and affects inappropriate fetal development. The deficiency of these mineral components is often observed in young women-potential mothers. Increasing during pregnancy the need for nutrients and abnormal nutrition, intensify the deficiencies of minerals and affect the abnormal development of the fetus. It seems that during the course of pregnancy, changes in the mineral nutrition of women can be observed, which is why it is important to monitor this condition in the subsequent months of pregnancy. Due to the above, the aim of the planned research is to determine the nutrition and nutritional status of women in the subsequent trimesters of pregnancy. Obtained results will allow to formulate appropriate nutritional recommendations and / or indicate the need to implement appropriate mineral supplementation for women in every trimester of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2018
CompletedFirst Submitted
Initial submission to the registry
July 1, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2028
March 27, 2026
March 1, 2026
9.8 years
July 1, 2018
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
minerals (Ca, Mg, Fe, Zn)
measure minerals in serum, hair, amniotic fluid
1 year
Secondary Outcomes (8)
maternal anthropometric parameters
2 years
fetal body weight
2 years
fetal head circumference
2 years
fetal biparietal diameter
2 years
prenatal diagnosis: PAPP-A
2 years
- +3 more secondary outcomes
Eligibility Criteria
A group of approximately 300 women is planned to be included in the study in the first trimester of pregnancy (up to 14 weeks of pregnancy).
You may qualify if:
- Diagnosed intrauterine pregnancy until week 14.
- Single pregnancy without congenital malformations in ultrasound examination.
- Lack of exponents threatening miscarriage (bleeding, lower abdominal pain, chorionic hematoma).
- Lack of use of drugs affecting the mineral metabolism of the body.
- Signing consent to participate in the study.
You may not qualify if:
- Ectopic or heterotopic pregnancy.
- Twin pregnancy (or other multiple pregnancy).
- Obstetric load in the direction of numerous miscarriages, premature births under 34 weeks, pregnancy, fetal growth disorders (hypotrophy, macrosomia).
- Congenital and /or genetic defects found in current pregnancy or in the patient.
- Supply of drugs affecting the mineral metabolism of the body.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poznan University of Life Sciences
Poznan, 60-624, Poland
Biospecimen
blood samples hair amniotic fluid
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principial Investigator
Study Record Dates
First Submitted
July 1, 2018
First Posted
July 26, 2018
Study Start
March 20, 2018
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
November 30, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03